ZCCN INFO
832171
WUXI JINGHAI
836547
KLT
831689
4
TIRAIN
430564
5
ZHONGKE MEILING
835892
US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 0.9586
- +0.0557+6.17%
Close Mar 14 16:00 ET
- 0.9500
- -0.0086-0.90%
Post 19:59 ET
4.25MMarket Cap-0.14P/E (TTM)
0.9789High0.8720Low935.53KVolume0.9100Open0.9029Pre Close865.45KTurnover21.10%Turnover Ratio0.00P/E (Static)4.43MShares219.480052wk High0.33P/B4.25MFloat Cap0.677552wk Low--Dividend TTM4.43MShs Float15288000.0000Historical High--Div YieldTTM11.84%Amplitude0.6775Historical Low0.9250Avg Price1Lot Size
About Allarity Therapeutics Company
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.
Company Profile
SymbolALLR
Company NameAllarity Therapeutics
Listing DateDec 21, 2021
Founded2021
CEOMr. Thomas H. Jensen
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address24 School Street,2nd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02108
Phone1-401-426-4664
Websitehttp://www.allarity.com
Company Executives
- Name
- Position
- Salary
- Thomas H. Jensen
- Chief Executive Officer and Director
- 24.72K
- Dr. Steen Knudsen, PhD
- Chief Scientific Officer
- 266.22K
- Dr. Jeremy Graff, PhD
- President and Chief Development Officer
- --
- Alexander Epshinsky
- Chief Financial Officer
- --
- Joan Y. Brown
- Director, Financial Reporting and Principal Accounting Officer
- 250.00K
- Gerald W. McLaughlin
- Chairman of the Board
- 107.38K
- Joseph W. Vazzano, C.P.A.
- Independent Director
- 29.17K
- Dr. Laura E. Benjamin, PhD
- Independent Director
- 27.71K
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025